A global platform for the Circular Bioeconomy
No Result
View All Result
Wednesday, November 29, 2023
World Bio Market Insights
  • Home
  • Insights
  • News
    • Technology
    • Business
    • Investment
    • Regulation
  • WBMI TV
  • Newsletter
    • Subscribe and Past Issues
    • Sponsorship Opportunities
  • Community Partners
  • WBM 2024
World Bio Market Insights
  • Home
  • Insights
  • News
    • Technology
    • Business
    • Investment
    • Regulation
  • WBMI TV
  • Newsletter
    • Subscribe and Past Issues
    • Sponsorship Opportunities
  • Community Partners
  • WBM 2024
No Result
View All Result
World Bio Market Insights
No Result
View All Result

Triplebar lands $20M financing for its food and biopharmaceuticals portfolio

by Daniela Castim
4 weeks ago
in Investment
Reading Time: 2 mins read

Triplebar, a bio-manufacturing company, has secured $20 million in funding to expand its product portfolio in food and biopharmaceuticals. The company’s Hyper-Throughput™ screening platform integrates hardware, software, biology, and biochemistry to accelerate evolution and miniaturize production. Triplebar’s commercial partners use the platform to develop animal cell lines for cellular meat products, produce low-cost and low-footprint animal proteins to replace traditional animal sources, and discover novel therapeutic biologic drug candidates for major human health challenges.

Synthesis Capital led the funding round, with participation from Essential Capital, Stray Dog Capital, iSelect Fund, and major investor The Production Board. The investment comes after several years of growth for Triplebar, which is a foundry business of The Production Board. TPB was the first and major investor in Triplebar and has a vision to re-engineer global production systems across food, agriculture, biomanufacturing, human health, and the broader life sciences.

Triplebar’s new funding will help it scale up production to bring entire portfolios of bioproducts to market and help a wide range of companies from incumbents to startups. In January 2023, Triplebar partnered with global ingredients giant FrieslandCampina to co-develop and scale up the production of ingredients essential to human nutrition. The two companies will produce microbial cells via fermentation methodologies, which can produce proteins with a much smaller land, water, and energy footprint than traditional livestock.

In early 2023, Triplebar also partnered with Umami Bioworks, a cultivated seafood platform company, to co-develop optimized cell lines suitable for large-scale production of cultivated seafood. Together, the two companies will work to improve the fitness and performance of cell lines to enable lower-cost, more efficient production of cultivated foods. Umami Bioworks will leverage Triplebar’s Hyper-Throughput™ screening platform for solution discovery and accelerate cell line development and optimization without the need for genetic modification.

Tags: News
Previous Post

Biomaterials startup erthos raises $6.5 M

Next Post

Solugen and ADM partner to scale sustainable products with new biomanufacturing facility

Related Posts

World’s first low-energy bioplastics raises $2M
Investment

World’s first low-energy bioplastics raises $2M

November 28, 2023
TômTex raises $4.5M for biodegradable shrimp leather
Investment

TômTex raises $4.5M for biodegradable shrimp leather

November 28, 2023
Europe mycelium market to hit $1.14B by 2028, report says
Investment

Europe mycelium market to hit $1.14B by 2028, report says

November 23, 2023
Aigen lands $12M funding for agtech robots
Investment

Aigen lands $12M funding for agtech robots

November 16, 2023
Phantm raises $2M to lead circular regenerative natural materials economy
Investment

Phantm raises $2M to lead circular regenerative natural materials economy

November 9, 2023
Algenesis secures funding to scale biomaterial production
Investment

Algenesis secures funding to scale biomaterial production

November 1, 2023

Latest News

World’s first low-energy bioplastics raises $2M

World’s first low-energy bioplastics raises $2M

November 28, 2023
TômTex raises $4.5M for biodegradable shrimp leather

TômTex raises $4.5M for biodegradable shrimp leather

November 28, 2023
Essity joins European research project on biobased circular tech

Essity joins European research project on biobased circular tech

November 27, 2023
Evlox, Recover and Jeanologia launch sustainable denim capsule collection

Evlox, Recover and Jeanologia launch sustainable denim capsule collection

November 27, 2023
  • Home
  • Insights
  • News
  • WBMI TV
  • Newsletter
  • Community Partners
  • WBM 2024

Please note: Bio Market Insights is owned and operated by TNP Media Ltd, after being acquired from Quantuma in April 2021.

Follow us

© Bio Market Insights

No Result
View All Result
  • Home
  • Insights
  • News
    • Technology
    • Business
    • Investment
    • Regulation
  • WBMI TV
  • Newsletter
    • Subscribe and Past Issues
    • Sponsorship Opportunities
  • Community Partners
  • WBM 2024

© 2023 World Bio Market Insights